ShareVitruvianMD, an innovative MedTech startup, recently raised $1.25 million (about R23 million) in their Seed Extension II funding t round. The funding was spearheaded by 27four’s impactful venture capital fund, The Nebula Fund, signifying a major achievement for the company as it drives its revolutionary technology ahead. Through the fusion of biomedical engineering and advanced artificial intelligence (AI), VitruvianMD is reshaping accessibility in the realm of medical laboratories. Launched in May 2023, the Nebula Fund has gained significant traction by prioritizing support for high-growth companies grounded in strong fundamentals. Under Naidoo’s leadership and with the expertise of 27four’s experienced private markets team, the Nebula Fund is well-positioned to influence the landscape of impact-oriented startups.

Source: The North Africa Journal August 21, 2023 14:22 UTC